Gene editing technology is a rapidly evolving area of clinical and translational research that combines the potential of great advances with profound ethical challenges. Join Medpace medical and regulatory experts to discuss the unique opportunity of this evolving technology as it applies to human diseases.
The session will include a discussion of:
- Basics of gene editing
- Potential applications
- Understanding clinical research challenges
- Regulatory considerations
- Ethical challenges and public perceptions
Watch the Webinar
Dr. Trevor Walker works collaboratively with the medical and operational teams to provide regulatory strategy and advice to ensure successful clinical development as well as leading specific regulatory activities. His global regulatory experience includes a variety of product types, therapeutic indications and geographic regions as well as a particular focus on advanced therapies. Trevor holds a DPhil in Pharmacology from Oxford University, and also has experience in manufacture of cellular therapies.
Trevor Walker, DPhil, Associate Director, Regulatory Affairs, Medpace
Blythe Thomson, M.D. -
Senior Medical Director, Hematology & Oncology, Medpace
Dr. Blythe Thomson serves as a Medical Monitor for hematology, oncology and hematopoietic cell transplantation studies at Medpace. She brings significant knowledge and experience to the topic of cellular therapy. She has provided medical leadership for cellular therapy trials during her professional career in both academia and industry.